Court Tosses Securities Fraud Charges Against ICN
In a turnaround for ICN Pharmaceuticals, a federal appeals court has affirmed a lower court's dismissal of securities fraud allegations brought in a class action more than two years ago, even...To view the full article, register now.
Already a subscriber? Click here to view full article